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1. Abstract 
In the last two decades, several publications dealt with the GM1-ganglioside rich 
domains of the cell membrane — also termed lipid rafts — as essential modulators of 
growth factor dependent signaling. These cholesterol- and sphingolipid-enriched 
submicron sized membrane domains possess not only structural, but also functional 
roles. Rafts are able to simultaneously isolate or accumulate diverse membrane 
proteins involved in various signaling pathways; furthermore, these platforms are also 
able to organize effector and adaptor proteins together with receptors in small 
membrane compartments, thus evoking more efficient signal transduction. 
In my PhD thesis I aim to demonstrate the modulatory and organizing function of 
GM1 rich microdomains in the membrane of tumor cell lines, and their possible role 
in targeted therapies. My observations encompass the significance of lipid rafts in 
serving as a platform for cell confluence dependent regulation of the functional 
outcome of signaling by the receptor tyrosine kinase PDGFR β, as well as for 
generating an apoptotic response to combination treatment with platinum complexes 
and TRAIL. Overall, my results support the view that GM1 rich microdomains are 
important regulators of various signaling pathways, and can be considered essential 
platforms for the optimal execution of cellular responses to external signals. 
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2. Introduction 
2.1. Lipid rafts 
Until the 1980s, it has been widely accepted that phospholipids and membrane 
proteins are randomly distributed in cell membranes, according to the Singer-Nicolson 
fluid mosaic model, published in 1972. In this model, the cell membrane was defined 
as a bilayer of amphipathic lipid molecules surrounding transmembrane proteins in 
greater or lesser amounts. Fluidity has been largely owed to horizontal displacement 
of lipid and protein components, while stability has been attributed to lateral 
interconnection between various proteins, and between proteins and lipids. Although 
the fluid mosaic model provided scientists with a new perspective of membrane 
structure, it was unable to answer a number of function-related questions. 
In the mid-eighties, some new studies have pointed out that biological membranes 
are not only randomly distributed lipid bilayers with uncontrolled diffusion of integral 
and peripheral proteins, but rather they are hierarchically structured cell 
compartments, with complex physical nature influenced by lateral heterogeneity. 
According to some new hypotheses from these years, the cell membrane was 
described as a lively, dynamic structure with heterogeneous and ever-changing 
permeability, fluidity and mobility characteristics. Increased organization of lipids and 
proteins, furthermore their intermolecular communication hinted that unique, 
submicron motives in cell membranes have an essential role in the regulation of 
important cell functions. 
In 1997, Simons and Ikonen described some new, well organized membrane 
structures built of sphingomyelin, glycolipids, cholesterol and GPI-anchored proteins, 
and exhibiting intramembrane mobility. These organized membrane domains were 
termed lipid rafts, or detergent resistant membrane domains (DRM). Cholesterol is an 
essential molecular component of rafts, but they also contain exoplasmic sphingolipids 
and endoplasmic phospholipids linked to membrane proteins by their acyl chain. 
According to this new model, the plasma membrane is a “sea” of disorganized lipids 
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with some scattered and well-organized free-cruising “raft” structures composed of 
cholesterol, sphingolipids and proteins.  
In the years following their initial proposition, evidence has accumulated that lipid 
rafts are not only structural units of the cell membrane, but they might have important 
functional roles. It was hypothesized that clustered organization of the lipid bilayer 
has an impact on the function and distribution of GPI-anchored transmembrane 
proteins, such as the Lck tyrosine-kinase, Src kinases and some G-proteins. 
One of the important consequences of lipid protein interaction is the flexible, 
environment-dependent structure and function of the rafts. It was observed that 
following stimulation, small lipid domains easily melt together and form larger units. 
It was also proposed that various proteins can be recruited into, or excluded from these 
domains dynamically, as required by function. This notion, incorporated into the 
dynamically structured mosaic model, also brought with it the conviction that protein-
protein and protein-lipid interactions have similar importance as the forces building 
structured and less organized domains out of various lipids. The model also proposed 
that lipid rafts hosting specific protein-lipid interactions are able to increase the 
lifetime of intermolecular interactions required for efficient signaling, as well as 
facilitate the binding of membrane surface proteins to cytoplasmic adaptor and 
regulatory proteins, or cortical actin cytoskeleton. 
In the last decade, development in the fields of microscopy and immunofluorescent 
staining made possible the precise observation of lipid raft structure and function. 
According to recent publications, the size of detergent resistant membrane domains 
varies from membrane rings measuring a few nanometers, through small islands 
measuring below a hundred nanometers to clusters measuring hundreds of 
nanometers. Although the lipid composition of various sized membrane microdomains 
also varies, incorporation of glycosphingolipids and cholesterol is common feature. 
Binding of cholera toxin B-subunit to ganglioside GM1 was one of the earliest 
markers to identify lipid rafts. 
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2.2. Receptor models for the investigation of lipid raft function 
2.2.1. The PDGF receptor 
 
Platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) have been 
demonstrated as prototypes for growth factor and receptor tyrosine kinase function for 
more than 30 years. PDGF stimulates migration and proliferation of connective tissue 
cells and has an important role during embryonic development and wound healing, but 
its abnormal expression also contributes to a variety of diseases. PDGF and its 
receptor are currently under investigation as targets in numerous proliferative 
disorders, including cancers, fibrosis, and cardiovascular diseases. PDGF was 
identified from the alpha-granules of human thrombocytes in the 1970s as an essential 
soluble growth factor for normal fibroblast, smooth muscle cell and glial cell function. 
According to the original hypothesis, PDGF consisted of two different polypeptide 
chains — PDGF-A and PDGF-B — linked together as a heterodimer (PDGF-AB). 
Finding of PDGF-AA and PDGF-BB forms expanded the PDGF family to three 
proteins encoded by two genes, PDGF-A and PDGF-B. In the first years of the 21st 
century, characterization of two additional PDGF genes and proteins — PDGF-C and 
PDGF-D — has further expanded our understanding of this complex signaling system. 
The binding of the PDGF dimer formed from the A and/or B polypeptide chains 
leads the formation of a receptor dimer similarly composed of α and β chains. The β-
type receptor executively binds the B subunit, whereas α-type receptors are able to 
bind both A and B subunits. Expression of PDGFR α was demonstrated on the surface 
of mesenchymal cells such as chondrocytes, oligodendrocytes and alveolar 
macrophages, while PDGFR β plays an important role in the regulation of malignant 
human gliomas. Expression of the PDGF ligand and its receptor correlates with tumor 
grade and proliferative activity.  
PDGF evokes its effect on target cells through activating the intrinsic tyrosine 
kinase of its receptor upon dimerization, which induces autophosphorylation of the 
tyrosine 857 residue and is essential for the autoactivation of the receptor. 
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Consequently generated further phosphotyrosine residues serve as docking sites for 
proteins possessing a Src homology 2 (SH2) domain or a phosphotyrosine binding 
(PTB) domain and initiate downstream signaling. On PDGFR, tyrosine 716 (Tyr716) 
is an important residue which binds the growth factor receptor binding protein-2 
(GRB2). This SH2 domain protein activates the Ras-MAPK pathway which plays a 
central role in cell proliferation. Dephosphorylation of Tyr716 by protein tyrosine 
phosphatase PTPN1 (PTP1B) inhibits PDGF-induced activation of the ERK1/2 MAP 
kinases. Negative regulation of this pathway is mediated by the phosphorylation of 
tyrosine 771 (Tyr771) leading to the binding of RasGAP, the GTPase activator of Ras. 
Phosphorylation of Tyr771 is regulated by protein tyrosine phosphatase PTPN11 
(SHP-2). Decreased recruitment of RasGAP leads to prolonged activation of the Ras-
MAP kinase pathway and thus promotes cell proliferation.  
Tyrosine 751 (Tyr751) is situated in the kinase insert region and binds the 
regulatory p85 subunit of phosphatidylinositol 3-kinase (PI3-kinase). The 
phosphatidylinositol (3,4,5)-trisphosphate (PtdIns(3,4,5)-P3) generated by PI3-kinase 
enhances the activity of the pro-survival Akt kinase. PTPN1 is also able to 
dephosphorylate Tyr751 on PDGFR, thus decreasing activation of Akt.  
Tyrosine 1021 (Tyr1021) is known as the binding site of phospholipase C-γ1 
(PLCγ). PLCγ initiates the inositol 1,4,5-trisphosphate (Ins (1,4,5)-P3) / diacylglycerol  
pathway, which mediates intracellular calcium mobilization and protein kinase C 
(PKC) activation and is important in the regulation of cell migration via RhoA.  
Our earlier results have shown that cells of confluent A172 glioblastoma cultures, 
but not of sparse ones, exhibit a sustained two-phase calcium rise upon PDGF 
stimulus. Furthermore, expression of PDGFR β in these cells increased with 
confluence of the culture and these receptors were mainly localized to GM1 rich lipid 
microdomains.  
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2.2.2. The TRAIL receptor 
 
The main goal of anticancer therapy is to selectively induce apoptosis in cancer 
cells while sparing untransformed cells and healthy tissues. One promising approach 
is to trigger the extrinsic apoptotic pathway by tumor necrosis factor-related 
apoptosis-inducing ligand (TRAIL), a member of the tumor necrosis factor 
superfamily, which has been shown to selectively induce apoptosis in various cancer 
cells in vitro and in vivo. The mechanism of differential sensitivity to TRAIL in 
normal and cancer cells is still a matter of debates among the experts. Several 
potential ways of resistance of non-tumorigenic cells to TRAIL have been proposed so 
far, at the level of both surface and intracellular molecules. Furthermore, many tumor 
cells have been shown to be resistant to the effects of TRAIL due to deficiencies in 
apoptotic pathways or over-activated prosurvival signaling. Elucidation of the 
molecular mechanisms of resistance and designing safe combination therapies using 
agents capable of sensitizing cancer cells but not normal ones to TRAIL-induced 
apoptosis are important prerequisites of the successful clinical application of this 
cytokine. 
There are five known types of TRAIL receptors. Death receptors (DRs) DR4 
(TRAIL-R1) and DR5 (TRAIL-R2) containing a death domain (DD) are responsible 
for transmitting the apoptotic signal, whereas decoy receptors (DcRs) DcR1 (TRAIL-
R3, lacking DD) or DcR2 (TRAIL-R4, with truncated DD), and a soluble receptor 
osteoprotegerin (TRAIL-R5) are unable to signal apoptosis. Intriguingly, the cell 
surface expression of a particular TRAIL receptor may not fully correlate with its 
functional importance in inducing or inhibiting apoptotic TRAIL signaling. 
DR4 and DR5 mediate TRAIL-induced apoptosis by recruiting Fas-associated DD 
protein and pro-caspase-8 to form a death-inducing signaling complex (DISC). The 
amount of caspase-8 activated by the DISC is an important factor affecting further 
progression of apoptotic signaling. In so-called type I cells, abundantly activated 
caspase-8 directly cleaves and activates effector caspases, which leads to direct 
implementation of cell death. In type II cells, the amount of caspase-8 activated by the 
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DISC is not sufficient to trigger adequate effector caspase stimulation; therefore, 
amplification of the apoptotic signal via mitochondria is required.  
The initial steps of TRAIL signaling have been studied intensively, especially the 
expressional regulation of the TRAIL receptors, their translocation to the cell surface, 
plasma membrane distribution, lipid raft localization and internalization. Recent 
studies have suggested the role of lipid rafts as platforms for DR-mediated apoptotic 
signaling. Relocation of TRAIL DRs into lipid rafts has been shown to facilitate DISC 
formation and apoptosis mediated by caspase-8 activation, whereas TRAIL-DISC 
assembly in the non-raft regions of the plasma membrane resulted in inhibition of 
caspase-8 cleavage and promotion of antiapoptotic signaling.  
Combined treatment with chemotherapeutic drugs has been shown to overcome 
TRAIL resistance in many cancer cell types. Diverse molecular mechanisms have 
been proposed to be responsible for the synergistic effects of these agents in inducing 
apoptosis of target cells. Chemotherapy may have a great impact on the crucial steps 
of the TRAIL signaling pathway, e.g. through increase of TRAIL DR expression, lipid 
raft localization, decrease of the cellular level of FLICE-like inhibitory proteins, 
facilitating DISC formation and caspase-8 activation, up/downegulation of 
pro/antiapoptotic molecules, or stimulation of mitochondria. 
Platinum complexes, e.g. cisplatin, carboplatin and oxaliplatin belong to the most 
widely used chemotherapeutic agents in the treatment of solid cancers. By creating 
covalent bonds with DNA, they induce DNA damage signaling, which leads either to 
cell cycle arrest providing time to repair the damage or to immediate activation of 
apoptotic signaling via the intrinsic mitochondrial pathway and killing of cancer cells. 
In the past two decades, plenty of newly synthesized analogues of platinum complexes 
including Pt(IV) complexes were assessed and some of them have entered clinical 
trials. LA-12 is a novel adamantylamine containing Pt(IV) complex currently in phase 
I clinical trials. In vivo studies on murine xenografts revealed a higher antitumor 
activity of LA-12 than that of cisplatin or the Pt(IV) complex satraplatin, as well as 
enhanced tissue penetration and lower acute systemic toxicity. 
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Due to its improved hydrophobicity, LA-12 was shown to effectively penetrate 
tissues and tumors and can be administered orally. These data imply that LA-12 is a 
promising candidate for cancer therapy, with high efficiency in killing cancer cells in 
vitro and in vivo and low toxic side effects in vivo. 
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3. Aims 
In this work, we have investigated the role of lipid rafts in growth factor receptor 
and death receptor signaling, as well as the programmed cell death of cancer cells.  
We tried to answer the following questions: 
 
 Do lipid rafts and cell confluence have any regulatory significance 
for the receptor tyrosine kinase PDGF β in glioblastoma cells? 
 
 Do lipid rafts play a role in the apoptotic response induced by the 
combination of platinum complexes and TRAIL? 
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4. Materials and methods 
4.1. Cell lines 
Lipid raft dependent regulation of β-type PDGF receptor was measured on A172 
and T98G human glioblastoma cells, maintained in a humidified incubator at 37°C in 
a 5% CO2 atmosphere in DMEM medium supplemented with 10% fetal calf serum 
and antibiotics. The cells were passaged three times a week.  
We used sparse (low density) and confluent (high density) cell cultures. Initial cell 
concentration was 15,000/cm2 for sparse and 60,000/cm2 for confluent conditions. 
Cells were cultured for 2 days before measurements, unless otherwise mentioned. 
For Western blot experiments, cells were seeded onto cell culture dishes. For 
sparse and confluent cultures 570,000 cells were seeded in 100 mm and 35 mm Petri 
dishes yielding an initial density of 7,250 and 60,000 cells/cm2 for sparse and 
confluent samples, respectively. Cells were cultured for 2 days before measurements. 
Effect of platinum complexes on the colocalisation of lipid rafts and TRAIL 
receptors was measured on HCT-116 human colon adenocarcinoma and PC-3 prostate 
epithelial cancer cell lines maintained in McCoy’s 5A modified medium 
supplemented with 10% heat-inactivated fetal calf serum and antibiotics. Cells were 
incubated in a humidified incubator at 37°C in a 5% CO2 atmosphere and passaged 
twice a week. For confocal microscopy, cells were seeded onto 12 mm glass 
coverslips. 
4.2. PDGF ligand stimulation of glioblastoma cells 
Before experiments, A172 and T98G cell lines were starved in serum-free HEPES 
buffer, pH 7.4, for 2h at 37°C. Ligand stimulation of PDGFR β was done at 37°C with 
recombinant PDGF-BB (the homodimer of the B isoform of platelet derived growth 
factor) used at a final concentration of 20 ng/ml in 50 l solution, the lowest dose 
previously established to cause maximum calcium signals in confluent glioblastoma 
cell cultures. For microscopy experiments, ligand stimulation was 2min when 
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measuring receptor phosphorylation, and 2h for assessing migration and proliferation. 
For Western blot-based analysis of signaling, PDGF-BB stimulation was performed 
for 1, 2, 5, 15, 30 and 60 min in order to obtain a time-function of events. 
4.3. TRAIL ligand stimulation and platinum-complex treatment of colon and 
prostate carcinoma cells  
Before experiments, HCT-116 and PC3 carcinoma cell lines were starved in 
serum-free HEPES buffer, pH 7.4, for 2h at 37°C. Ligand stimulation of TRAIL 
receptors and platinum treatment were done at 37°C with recombinant TRAIL used at 
a final concentration of 5 ng/ml, cisplatin used at a final concentration of  and 
LA-12 used at a final concentration of in 50 l solution. Cells were incubated 
for 5-60 minutes at 37°C, then washed with ice cold HEPES buffer.  
4.4. Immunofluorescent labeling 
Glioblastoma, colon and prostate cancer cell lines on coverslips were washed three 
times in ice-cold HEPES buffer and incubated with specific monoclonal antibody for 
10 min on ice. After three washes, fluorescent dye conjugated secondary antibody  
was added at 15 μg/ml together with 4 μg/ml Alexa Fluor 488-conjugated cholera 
toxin B-subunit for 10 min on ice. After three washes cells were fixed with 4% 
formaldehyde on ice and allowed to warm to room temperature. 
 Intracellular staining of specific Tyr716, Tyr751, Tyr771 and Tyr1021 
phosphotyrosine residues, pRhoA, cortactin and Ki-67 proteins on glioblastoma cells 
was performed immediately after extracellular labeling, or after fixing cells with 1% 
formaldehyde for 10 min on ice. The cell membrane was permeabilized with HEPES 
buffer containing 0.1% Triton-X 100 and 1% BSA for 10 min. Following incubation 
with the appropriate monoclonal antibodies for 35 min at RT, cells were washed three 
times with HEPES buffer containing 0.05% Triton-X 100. Primary antibodies were 
labeled with Cy3, Alexa Fluor 546 or Alexa Fluor 647 conjugated secondary 
antibodies. After three washes, cells were fixed with 4% freshly depolymerized 
paraformaldehyde. Finally, the coverslips were mounted with Mowiol.  
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4.5. Confocal Laser Scanning Microscopy 
Membrane distribution of PDGFR β and its phosphotyrosine residues was 
quantitatively analyzed by a confocal laser scanning microscope (LSM 510, Carl Zeiss 
GmbH, Jena, Germany). Alexa Fluor 488 was excited at 488 nm, Cy3 and Alexa Fluor 
546 at 543 nm, and Alexa Fluor 647 at 633 nm. Their fluorescence emission was 
detected through 505 to 550-nm, 560 to 615 band-pass and 650-nm long-pass filters, 
respectively. The images were taken in multitrack mode to exclude channel cross talk. 
512 × 512-pixel, 1.5 μm thick optical sections were obtained with a 40× C-
Apochromat water immersion objective (NA=1.2). 
4.6.  Digital image processing 
4.6.1. Determining colocalization from image cross-correlation 
Colocalization of any two molecules at the few-hundred-nanometer scale was 
determined from confocal laser scanning microscopy images of double-labeled cells. 
 The optical section was taken from the top horizontal slice of the membrane of 
adherent cells. The images were gated on the presence (above-background intensity) 
of at least one of the fluorophores. A custom written program in LabView was used to 
analyze the images and calculate the crosscorrelation coefficient C. The theoretical 
maximum is C = 1 for identical images and a value close to 0 implies independent 
random localization of the two labeled molecules. 
4.6.2. Digital image processing for the quantitative analysis of specific 
phosphotyrosine distribution inside and outside of lipid rafts 
A quantitative digital image processing pipeline, created for this purpose in 
ImageJ, was used to calculate specific phosphotyrosine density inside and outside of 
lipid rafts. First, background intensities of phosphotyrosine and GM1 positive 
channels were subtracted. Two binary masks in inverse relation – raft and non-raft – 
were created and used to generate inside raft and outside raft phosphotyrosine images. 
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From these, probability distribution curves of pixel-intensities were generated, and the 
mean intensities calculated.  
4.6.3. Digital image processing for the quantitative analysis of specific 
relative receptor phosphorylation inside and outside of lipid rafts 
The ImageJ algorithm developed for this purpose starts by subtracting the 
background in the PDGFR, phosphotyrosine and GM1 channels, and then normalizes 
the intensity of the specific phosphotyrosine label to the total PDGFR on a pixel by 
pixel basis. The image thereby generated represents the relative specific PDGFR 
phosphorylation on the cell surface. Raft and non-raft binary masks are then created 
from the GM1 channel and applied to calculate the mean relative receptor 
phosphorylation inside and outside of lipid rafts. Finally, the inside raft value is 
normalized by the outside raft value, so that acquisition parameters that could change 
across experiments are canceled to allow the pooled evaluation of results from many 
independent experiments. Values of the final quotient above and below 1 indicate 
preferential phosphorylation and dephosphorylation, respectively, of a given tyrosine 
residue inside rafts. 
4.7. Western blotting 
Cell lysates were prepared from sparse and confluent A172 and T98G cell lines. 
Cells were washed with ice cold HEPES buffer and lysed with lysis buffer. Protein 
concentration was measured according to Bradford, samples were diluted with SDS-
PAGE sample buffer to contain the same concentration of total protein and finally 
boiled for 10 min. Proteins (20 µg per well) were separated by 6-12% SDS-PAGE 
gels depending on the targeted molar mass, and electrophoretically transferred to 
polyvinylidene difluoride membranes. Membranes were blocked for 60 min with TBS 
buffer supplemented with 5% dry milk, then incubated with specific monoclonal 
antibodies. After overnight incubation on a rocking table at 4°C, membranes were 
washed with TBS-T for 30 min at room temperature, and then peroxidase-conjugated 
secondary antibody was added for 2 hours. After a 30 min wash with TBS-T, 
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membranes were developed with Super Signal West Pico Chemiluminescent Substrate 
and imaged with a FluorChem Q system.  
4.8. Assessment of cell proliferation 
Proliferation in confluent and sparse cultures was measured using an MTT based 
colorimetric assay. Cells plated at various densities were grown in 96-well plates for 2 
days. After incubation with EZ4U, a Synergy HT Multi-Detection microplate reader 
was used to measure 488 nm absorption, which, corrected with the 620 nm absorption 
was converted to cell numbers using a calibration curve from freshly plated and 
adhered cells seeded at various densities.  
To follow the growth rate in real time, impedance based real time cell 
adherence assay (RTCA) was performed using an ECIS ZΘ analyzer. T98G cells 
seeded at low and high densities were grown in 8W10E PET 8 well arrays with gold 
electrodes at the bottom. Weak alternating current was applied at frequencies from 1 
to 100,000Hz to continuously measure the complex impedance spectrum of cells 
adhering to each electrode in the well. The measured impedance at any time point is 
proportional to the area of the electrode covered by cells. Impedance values from 4 
wells were averaged, normalized to initial cell number, and plotted as a function of 
time. 
4.9. Statistical analysis 
The data from lipid raft and cell confluence dependent regulation of PDGFRs was 
statistically analyzed by two-way analysis of variance followed by Tukey’s test. 
Lipid raft dependent synergism of platinum complexes and TRAIL receptors was 
analyzed by ANOVA followed by Tukey’s test, or by a nonparametric Mann–Whitney 
U-test.  
All statistical analyses were performed by the XLSSTAT module supplemented 
MS Office Excel 2010 software. A P value of <0.05 was considered significant. 
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5. Results and discussion 
5.1.  Cell confluence and lipid raft dependent regulation of PDGFR β on 
glioblastoma cell lines 
5.1.1.  PDGFR β clusters in the cell membrane co-localize with lipid rafts 
Preliminary experiments have shown that expression of PDGFR β on A172 and 
T98G glioblastoma cells increases with the confluence of cells in culture and that 
these receptors are mainly localized to GM1 rich lipid microdomains. We have 
employed confocal microscopy yielding 1.5 micron thick optical slices of the upper 
cell membrane to quantitate the degree of overlap between clusters of PDGFR β and 
lipid rafts. Colocalization was quantified by calculating the crosscorrelation 
coefficient. Overlap of PDGFR with lipid rafts was directly proportional to the 
confluence of the monolayer, regardless of whether cells were seeded at varying 
densities and measured after having adhered to the substrate, or seeded at the same 
density, and left to grow continuously over several days to reach increasing levels of 
confluence. This indicates that cell culture confluence as a state, and not the process of 
reaching it regulates receptor expression and raft localization. 
5.1.2.  Lipid raft and cell confluence dependent regulation of PDGFR β 
To investigate whether the confluence dependent raft localization of the receptors 
has any functional consequence, we have quantitated by immunofluorescence the 
amount of specific phosphotyrosine residues inside and outside GM1 rich membrane 
domains both in resting and PDGF-BB stimulated cells. The pixel by pixel distribution 
of specific phosphotyrosine residues both inside and outside lipid rafts was calculated. 
Sparse cultures exhibited basal phosphorylation of Tyr716 inside rafts slightly 
higher than confluent cultures, and showed a greatly increased activation upon 
stimulation with PDGF-BB, whereas p-Tyr716 hardly increased in rafts of confluent 
cells upon stimulus.  
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Basal phosphorylation of Tyr751 was 1.6x higher in sparse than in confluent 
cultures. Following PDGF-BB stimulus, sparse cells showed increased 
phosphorylation inside lipid rafts. 
Cell confluence had no prominent effect on the distribution of Tyr771 residue. 
Following PDGF-BB stimulation Tyr771 was more phosphorylated in confluent 
cultures, with a dominance of lipid raft-localized receptors 
Tyr1021 phosphorylation was globally higher in GM1 rich membrane areas, and 
exhibited considerable increase upon ligand stimulation in confluent cells. 
5.1.3. Relative specific phosphorylation of PDGFR β is a function of both 
cell confluence and lipid raft localization 
Stimulation induced effects on the cell surface distribution, raft localization and 
activation of PDGF receptors was simultaneously observed by triple 
immunofluorescent staining. We measured confluence dependent expression, specific 
tyrosine phosphorylation and raft localization of PDGFR in membrane before and 
after PDGF-BB stimulation. While Tyr716 and Tyr751 residues were primarily 
phosphorylated in GM1 rich domains of sparse cultures, Tyr771 and Tyr1021 
activation was increased in rafts of confluent cells. 
A quantitative digital image processing pipeline was used to determine the relative 
specific phosphorylation inside and outside of lipid rafts. We concluded that in 
unstimulated cells the dephosphorylated state of specific tyrosine residues dominated 
in rafts with the exception of Tyr1021. 
Following PDGF-BB ligand stimulation, distinct activation profiles of sparse and 
confluent cells were observed for specific tyrosine residues, with major changes from 
resting to stimulated state occurring in lipid rafts. Tyr716 involved in the Ras-MAPK 
pathway was phosphorylated in sparse, while Tyr771 inhibiting the same pathway was 
activated in confluent cells. 
Activation of Tyr751 regulates cell survival by initiating the PI3-Kinase pathway. 
PLCγ responsible for calcium transients and cell migration is activated on Tyr1021. 
We found that activation of Tyr751 was dominant in the membrane of sparse cells, 
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while Tyr1021 phosphorylation was increased in the GM1 rich domains of confluent 
cells. 
5.1.4.  Activation of the Ras-MAPK pathway and consequential cell 
proliferation dominates in sparse cultures 
To confirm confluence dependent selective tyrosine phosphorylation and test the 
activation of relevant downstream signaling pathways, Western blot analysis was 
performed. Also, to reveal whether the finding can be generalized, a second PDGFR 
expressing glioblastoma cell line, T98G, was examined in addition to A172 cells. 
In accordance with microscopic data, levels of p-Tyr716 which activates the Ras-
MAPK pathway showed a transient increase in sparse cultures of both cell lines 
following PDGF-BB ligand stimulation, and no change in confluent cells. Conversely, 
increased phosphorylation of the Tyr771 residue, which activates Ras-GAP, an 
inhibitor of the pathway, was more prominent in confluent cultures, although some 
transient phosphorylation was also seen in sparse cultures. Next, we measured the 
phosphorylation of two effector MAPK isoforms, p38 MAPK, and p42/p44 MAPK. 
Coherent with the specific phosphorylation of tyrosine residues activating and 
inhibiting these MAP kinases, both p38 and p42/p44 were activated mainly in sparse 
cultures. We have observed a time delay between the activation of receptors and 
effector proteins: while Tyr716 and Tyr771 were maximally phosphorylated within 1-
2 minutes of ligand stimulus, and by 15 min were already back to baseline, activation 
of effector MAP kinases peaked in the range of 5 – 30 minutes, land lasted through the 
60 min observation period 
As logically expected, phosphorylated p38 MAPK, and also p42/44 MAPK were 
increased in sparse cultures upon PDGF stimulus, in coherence with increased Tyr716 
phosphorylation. Meanwhile, in confluent cells, MAPK phosphorylation was low, 
partly owed to the lower levels of p-Tyr716, and partly to the strong phosphorylation 
of Tyr771, which inhibits the MAPK pathway by activating RasGAP. 
Since activation of the MAP kinase pathway is expected to influence cell 
proliferation, accumulation of the Ki-67 proliferation marker in cell nuclei was also 
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assessed by fluorescence microscopy. In line with increased MAPK activation in 
sparse cultures, we found greatly increased Ki-67 protein levels in the nuclear region 
of ~ 85% of the cells in sparse cultures two hours after PDGF stimulus. Coherent with 
low MAPK activation, the proportion of highly Ki-67 positive cells was only 1% in 
confluent cultures, and a further 12% exhibited a slight increase. Both MTT based and 
real time proliferation assays confirmed that the rate of proliferation is at least twice as 
high in sparse cultures as in confluent ones. Without stimulus, no signs of proliferation 
were detected in either sparse or confluent serum starved cell cultures. 
5.1.5.  Activation of the PLCγ pathway and consequential cell migration 
dominates in confluent cultures 
Phosphorylation of Tyr1021 occurred both in sparse and confluent cells, started by 
the first minute of stimulation, but was over within half an hour. Confluent cells 
showed markedly higher p-Tyr1021 than sparse cells of both cell lines. The 
phosphorylation of RhoA, an important effector activated along the PLCγ / PKC 
pathway was correspondingly also greatly increased in confluent cells, while in sparse 
cells it remained at baseline with only a slight increase at 2-15 minutes. We also 
observed that by two hours RhoA phosphorylation can even be below the baseline 
seen in unstimulated cells, while in confluent cells it is still maintained at a very high 
level. 
Based on this observation, we hypothesized that activation of the PLCγ pathway in 
confluent cells has a functional consequence on cell migration. Cortactin is an 
important protein facilitating polymerization and rearrangement of the actin 
cytoskeleton, promoting the formation of lamellipodia, invadopodia, and cell 
migration. In our confocal experiments, cellular localization and rearrangement of this 
protein to the leading edges were oppositely regulated in sparse and confluent 
cultures. In resting sparse cells, cortactin was mostly localized to the polarized cell 
front protrusion but decreased in quantity and appeared perinuclearly two hours after 
stimulus. In unstimulated confluent cultures, cortactin dominantly showed 
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cytoplasmic localization, but following PDGF-BB stimulation, it cumulated in the 
polarized leading cell front.  
5.2.  Platinum complex based chemotherapeutic agents and TRAIL induce 
DR4 and DR5 mediated, caspase-8 regulated apoptosis in a lipid raft 
dependent manner 
5.2.1. Trail receptors form clusters on the cell surface and colocalize with 
lipid rafts 
In our experiments we examined the sensitizing effect of LA-12, a novel platimun-
complex on the TRAIL mediated apoptosis of colon and prostate cell lines. We also 
compared its efficiency and its raft-related effects with the strong and widely used 
chemotherapy drug, cisplatin.  
We determined that DR4 and DR5 type TRAIL receptors form clusters on the 
surface of PC-3 prostate and HCT-116 colon carcinoma cells and colocalize with 
GM1 rich microdomains of the membrane. Based on this observation we hypothesized 
that the plasma membrane is an important factor in regulating the LA-12 or cisplatin 
induced extrinsic apoptotic pathway. 
5.2.2. Surface expression of TRAIL receptors is increased upon 
treatment with platinum complexes 
We also observed that treatment for 1h with either 10 M cisplatin or 0.5M LA-
12 increased the expression of TRAIL receptors by 20-200% in both examined cell 
lines. Cisplatin treatment of the HCT-116 cell line especially increased the expression 
level of the DR5 TRAIL receptor, while LA-12 treatment of the PC-3 cell line 
affected most prominently that of the DR4 TRAIL receptor. 
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5.2.3. Lipid raft localization of TRAIL receptors was increased upon 
treatment with platinum complexes 
After 1 h of cisplatin or LA-12 treatment, the colocalization between lipid rafts and 
TRAIL receptors DR4 and DR5 increased in both HCT-116 and PC-3 cells. Compared 
to controls, DR4 raft localization increased significantly in PC-3 cells after LA-12 
treatment, while DR5 showed a significant increase in HCT-116 owed to cisplatin, 
and in PC-3 owed to both platinum complexes. 
5.2.4. Short term TRAIL treatment increases lipid raft localisation of 
DR4 and DR5 rceptors 
We examined the effects of TRAIL ligand stimulation on raft localization of DR4 
and DR5 receptors. We found that short term (5-20 min) TRAIL stimulation at 5ng/ml  
increased the raft localization of both DR4 and DR5 receptors on both cell lines. 
Following 1 hour treatment, raft localization of the TRAIL receptors fell below the 
baseline on HCT-116 and PC-3 cell lines, most likely owed to internalization. 
5.2.5. LA-12- or cisplatin-mediated potentiation of TRAIL-induced 
cytotoxicity is associated with activation of the apoptotic caspase 
cascade 
In order to examine whether cytotoxicity induced by the combination of platinum 
complexes and TRAIL occurred via activation of the caspase cascade and apoptotic 
signaling, analysis of the cleavage of caspase-8, and caspase-3 was performed by 
Western blotting. Pretreatment with cisplatin or LA-12, followed by TRAIL, resulted 
in a substantial potentiation of the cleavage of pro-caspase-8, and pro-caspase-3 in   
both cell lines. 
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6. Conclusions 
6.1. Lipid raft and confluence dependent regulation of PDGF receptor β on 
glioblastoma cell lines 
Receptor tyrosine kinases of the PDGFR family play important roles in the 
proliferation and survival of cells, including those in glial tumors of the central 
nervous system. In this current study we described that PDGF receptors are mostly 
localized in submicron sized clusters on the cell surface. We also determined that the 
number, receptor density and lipid raft colocalization of these submicron sized clusters 
increases directly with cell confluence. Furthermore, we observed that receptor-raft 
interaction and cell confluence has high impact on the activation of various signaling 
pathways initiated on specific tyrosine residues of PDGFR β. Following PDGF-BB 
stimulation the Ras-MAPK pathway specific Tyr716 and the PI3-Kinase / Akt specific 
Tyr751 are phosphorylated primarily in sparse cultures, while Tyr771 phosphorylation 
which inhibits MAPK signaling decreases in these cells. In accordance with this 
observation, PDGF stimulus causes significantly higher MAPK phosphorylation and 
higher rate of Ki-67 antigen positivity, as well as at least twice higher proliferation 
rate in sparse cultures than in confluent ones. 
 At the same time, Tyr1021 activating phospholipase-C- and consequently the 
PKC pathway was highly activated in confluent cultures. We could observe the 
increased phosphorylation of downstream RhoA, and the redistribution of cortactin 
into leading edges, indicating increased mobility in confluent cultures.  
Tyrosine dephosphorylation and phosphorylation was dominantly performed in 
GM1 positive lipid domains. 
These observations suggest that the same stimulus is able to promote distinctly 
relevant signaling outputs through a confluence dependent, lipid raft-based regulatory 
mechanism. In particular, cell division in sparse cultures and inhibition of proliferation 
and promotion of migration in confluent monolayers.   
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6.2. Platinum complex based chemotherapeutic agents and TRAIL induce 
DR4 and DR5 mediated, caspase-8 regulated apoptosis in a lipid raft 
dependent manner 
TRAIL, a member of the tumor necrosis factor superfamily has been shown to 
selectively induce apoptosis in various cancer cells and to modify their resistance 
against other chemotherapy agents. Death receptors DR4 and DR5, containing a death 
domain, are responsible for transmitting the apoptotic signal of TRAIL. In this present 
study, we observed that both of examined platinum complexes increased the 
expression of TRAIL receptors in prostate and colon carcinoma cell lines. Cisplatin 
treatment had the greatest effect on DR5 receptors of colon cancer cell lines, while 
LA-12 treatment increased most eminently DR4 expression on prostate cancer cells. 
Both complexes increased the raft localization of TRAIL receptors on both cell lines, 
but LA-12 proved as effective as cisplatin in a concentration twenty times lower. 
TRAIL stimulation had a time dependent effect on receptor expression and raft 
localization. 5-20 minutes of TRAIL stimulation increased the expression and raft 
localization of receptors, but after one hour, raft localization decreased below the 
baseline, presumably owed to receptor internalization. The joint effect of platinum 
compounds and TRAIL on TRAIL receptor expression and raft localization can be 
exploited to induce apoptosis of cancer cell more effectively, as evidenced by the 
activation of caspases 8 and 3 in our model cell lines. This may offer potential clinical 
benefits when combining the two treatments. 
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7. Summary 
Cumulatively, our observations suggest that cholesterol and ganglioside enriched 
lipid microdomains of the cell membrane, also termed lipid rafts, are important 
regulators of various signaling processes. 
We have shown that PDGF and its receptor, using the organizing ability of lipid 
raft platforms, can initiate divergent signaling pathways as required by the sparse or 
confluent state of the cell population. Proliferation is activated is sparse, while 
migration in confluent cultures. Cell survival is regulated in a less divergent manner.  
We observed that platinum complexes widely used for cytostatic therapy increased 
the cell surface expression of TRAIL receptors and also their raft localization. Both of 
these effects result in a more effective signaling and increased apoptotic cell death. 
This newly observed lipid-raft dependent regulation has potential consequences in 
cancer therapy.  
Our results give an overview extending to clinical aspects about the diverse 
regulatory and organizing function of GM1 ganglioside rich membrane microdomains. 
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